Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review

Date: February 27, 2019
Pages: 25
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A35590384C0EN
Leaflet:

Download PDF Leaflet

Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review
Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact detai
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.

    Highlights

    Astex Pharmaceuticals Inc (Astex Pharmaceuticals) is a drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. The company’s proprietary fragment-based drug discovery platform, Pyramid which delivers, high-quality and customized drug leads across variety of therapeutic targets and disease areas. The provides joint oncology and CNS programs with sister companies, Otsuka Pharmaceuticals, and Taiho Pharmaceutical. Its pipeline product and programs includes DNMT inhibitor, Oral DNMT inhibitor, dual IAP antagonist and extracellular signal-related protein kinases inhibitor. Astex Pharmaceuticals is also advancing several of its compounds into clinical trials in collaboration with Novartis, AstraZeneca, GSK and Janssen. The company is a subsidiary of Otsuka Pharmaceutical Co Ltd. Astex Pharmaceuticals is headquartered in Pleasanton, California, the US.

    Astex Pharmaceuticals Inc Key Recent Developments

    May 16,2018: Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development

    Reasons to Buy
    • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
    • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
    • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
    • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
    Note: Some sections may be missing if data is unavailable for the company.

    NOTE: Out of security concerns GlobalData requires using corporate email address.
  • SECTION 1 - ABOUT THE COMPANY

    Astex Pharmaceuticals Inc - Key Facts
    Astex Pharmaceuticals Inc - Key Employees
    Astex Pharmaceuticals Inc - Key Employee Biographies
    Astex Pharmaceuticals Inc - Major Products and Services
    Astex Pharmaceuticals Inc - History
    Astex Pharmaceuticals Inc - Company Statement
    Astex Pharmaceuticals Inc - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Company Overview
    Astex Pharmaceuticals Inc - Business Description
    R&D Overview
    Astex Pharmaceuticals Inc - SWOT Analysis
    SWOT Analysis - Overview
    Astex Pharmaceuticals Inc - Strengths
    Astex Pharmaceuticals Inc - Weaknesses
    Astex Pharmaceuticals Inc - Opportunities
    Astex Pharmaceuticals Inc - Threats
    Astex Pharmaceuticals Inc - Key Competitors

    SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
    Astex Pharmaceuticals Inc, Recent Deals Summary

    SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

    May 16, 2018: Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development

    SECTION 5 – APPENDIX

    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Astex Pharmaceuticals Inc, Key Facts
    Astex Pharmaceuticals Inc, Key Employees
    Astex Pharmaceuticals Inc, Key Employee Biographies
    Astex Pharmaceuticals Inc, Major Products and Services
    Astex Pharmaceuticals Inc, History
    Astex Pharmaceuticals Inc, Other Locations
    Astex Pharmaceuticals Inc, Key Competitors
    Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
    Astex Pharmaceuticals Inc, Recent Deals Summary

    LIST OF FIGURES

    Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    COMPANIES MENTIONED

    Exelixis Inc
    Infinity Pharmaceuticals Inc
    Morvus Technology Ltd
    OncoMed Pharmaceuticals Inc
    Onyx Pharmaceuticals Inc
    Vertex Pharmaceuticals Inc
    Skip to top


    Sandoz Inc - Strategic SWOT Analysis Review US$ 125.00 Jul, 2018 · 41 pages
    SPI Pharma Inc - Strategic SWOT Analysis Review US$ 125.00 Jan, 2019 · 24 pages

    Ask Your Question

    Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: